Carcinogens Lawsuit In 2024

A carcinogens lawsuit involves prescription drugs that are carcinogenic or have the potential to cause cancer. In these types of lawsuits, the drug manufacturer or the marketer failed to warn or alert users that the use of their drugs could cause cancer. Below, we give you an update on pending carcinogens lawsuit claims.

Few things you might know about Zantac

Zantac has been one of the most popular antacid drugs since the 1980s. It was the 50th most prescribed drug, with more than 15 a million prescriptions annually. It was originally developed by the European pharmaceutical company Glaxo. Zantac was approved as a prescription drug in the United States in 1983.

Glaxo invested millions aggressively in advertising the drug to the general public and doctors. Consequently, it became one of the best-selling drugs in pharmaceutical history. After all, it was the first medication to reach $1 billion in annual U.S. sales.

Ranitidine and Zantac lawsuit updates

The ranitidine suits are moving forward particularly quickly. Plaintiffs’ lawyers believe that the Carcinogens or Ranitidine lawsuit settlement amounts could be worth more than $10 billion. Skilled and experienced attorneys are vigorously investigating these lawsuits for victims like you.

However, in September 2019, the U.S. Food and Drug Administration (FDA) issued a public safety warning regarding the hazardous cancer risks from Zantac. In the wake of the FDA safety warning, there was a Zantac recall, and ranitidine/Zantac was abruptly pulled from shelves across the country.

As of March 16, 2021, the total number of cases that filed multidistrict litigation (MDL) carcinogens cancer lawsuits  was pegged at 2,097. But with more than 70,000 census forms filled out at the last count, that number is likely higher in 2022. This results in a tolling agreement that pushes back the statute of limitations if you register your claim accurately.

Free Consultation




Disclaimer: By submitting the form above and checking the consent box, you agree to our conditions and privacy policy and permit Ethen Ostroff Law to contact you via text messages, phone calls (including automated calls). Standard message rates may apply.
Please Fill up Details and Check Captcha !!

carcinogens lawsuit

Plaintiffs claim defendants failed to warn about the Zantac cancer risk

The first and foremost claim in the carcinogens lawsuit is that the defendants failed to properly warn the public that Zantac’s active ingredient, ranitidine, is unstable and can form NDMA in the stomach leading to increased cancer risk. As a result, the plaintiffs demand to be compensated for injuries and pain and suffering.

Cancers that qualify for carcinogens lawsuit

The following types of cancer were found to be due to carcinogens:

  • Bladder.
  • Esophageal.
  • Gastric/Stomach.
  • Liver.
  • Pancreatic.

Who qualifies for a carcinogens lawsuit?

Your trusted carcinogens lawyers will help ensure you satisfy several conditions to potentially qualify for a lawsuit. In summary, the plaintiff would need to prove: 1) Zantac use, 2) a cancer diagnosis, and 3) a connection between the diagnosis and Zantac. Your carcinogens attorney will evaluate your claim and help gather medical records and evidence to build your case.

Potential claimants must prove that they took the brand name Zantac for at least one year before getting diagnosed with cancer. In addition, people who have a prescription can provide proof of prescription through their medical records. Those taking over-the-counter Zantac must have a receipt and other evidence that depicts they took the drug, such as a statement or doctor’s note. Choosing the top lawyers will help you gather the best evidence to prove usage.

The most dangerous injury claimed in carcinogens lawsuit is cancer. Potential claimants need to prove that they are diagnosed with bladder, esophageal, stomach, liver, or pancreatic cancer. However, there should be less than 20 years between the last time a potential claimant took Zantac and their first diagnosis. Moreover, the claimant should have received their diagnosis at age 89 or younger.

Generally, taking higher medication doses consistently can help prove the connection. The length of time someone has used the drug also affects their case. To qualify, you should have taken Zantac at least once a week for one year or longer.

Note that the top lawyers are only accepting claims from people who took the brand name Zantac. The generic ranitidine is no longer included in lawsuits.

Who should file a Carcinogens lawsuit?

If you have taken Zantac and developed cancer and are now facing medical bills, lost income, and poor health, filing a Zantac cancer lawsuit will help you get fair compensation for your past, present, and future medical costs.

What type of compensation will you get from the Zantac lawsuit?

  • Funeral expenses.
  • Lost ability to earn.
  • Loss of companionship.
  • Loss of a loved one.
  • Lost wages for you or a family member who may be your caregiver.
  • Medical bills.
  • Pain and suffering.
  • Travel for treatment.

Zantac lawsuit update 2024

The class-action suit against Zantac manufacturers is the first to officially schedule a trial date. Superior Court of Alameda Judge Evelio Grillo has set the start date for Ranitidine Product Cases JCCP 5150 for October 10, 2022.

According to a Ranitidine lawsuit update in October 2021, efforts to stop the Multidistrict Litigation (MDL) before the court in West Palm Beach, Florida were rejected. The U.S. District Judge Robin Rosenberg said that cases could proceed. To date, more than 800 cases are pending before Judge Rosenberg.

While the California trial is the first to be scheduled, trials in the MDL in Florida and an array of other cases in states such as Pennsylvania, Illinois, Minnesota, New Jersey, Texas, New York, Oregon, Tennessee, and Washington could be scheduled to start before the trial in Alameda.

The first trial before Judge Grillo is the first in a series of bellwether tests, starting with a case the plaintiffs selected. Next will be a case the defendants selected to begin on February 6, 2023. The next two are scheduled for May 1, 2023 (plaintiff selected) and August 7, 2023 (defendant selected).

Questions lawyers might ask before starting your claim

The lawyers handling your case will want to know that you were officially diagnosed and is qualified to file and get a fair carcinogens lawsuit compensation. Here is a list of questions the lawyers may ask of you:

  • What have you been diagnosed with?
  • How long did you take Zantac? People seeking compensation for Carcinogen-related injuries have taken Zantac for at least a year before receiving their cancer diagnosis.
  • How do you have a personal or family history of cancer? For this, you need to provide a copy of your medical records and be ready for discussion regarding the medical history.
  • Are you experiencing any other side effects while performing your day-to-day activities?

Ethen Ostroff Law is your one-stop platform to hire the best lawyers for your carcinogens claim. We will provide you with the best references that can help you get fair compensation for your lawsuit. Get in touch with us to discuss your case today.

Please complete the short form to have Ethen Ostroff Law review your case at no cost and in complete confidence. We will get back to you within 48 hours to discuss your situation. By submitting your case for review, you are agreeing to our Terms of Use.